Company Filing History:
Years Active: 2010-2013
Title: The Innovative Mind of Frank-Christophe Lintz: A Pioneer in Pharmaceutical Formulations
Introduction: Frank-Christophe Lintz, an accomplished inventor based in Starnberg, Germany, has significantly contributed to the field of pharmaceutical innovations. With two patents to his name, Lintz has focused on developing advanced formulations for the treatment and prevention of pulmonary bacterial infections. His work demonstrates a deep commitment to enhancing patient care through innovative solutions.
Latest Patents: Lintz's latest patents exemplify his expertise in pharmaceutical technology. The first patent describes an inhalable aztreonam lysinate formulation intended for the treatment and prevention of pulmonary bacterial infections. This method and composition are designed to effectively combat infections caused by gram-negative bacteria, especially those that are multidrug-resistant, through a concentrated formulation that can be delivered as an aerosol or dry powder.
The second patent showcases a pharmaceutical aerosol composition comprising sterile formulations that enable the administration of poorly water-soluble active agents. These compositions incorporate non-ionic surfactants and phospholipids, making them suitable for oral or nasal inhalation, as well as for topical or oromucosal administration. Particularly beneficial for the pulmonary administration of corticosteroids, these formulations can be aerosolized with typical nebulizers, thus improving the delivery and efficacy of medications.
Career Highlights: Over the years, Frank-Christophe Lintz has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Pari GmbH and Gilead Sciences, Inc., where he has leveraged his expertise to contribute to groundbreaking developments in treatment methodologies.
Collaborations: Collaboration has been integral to Lintz's success as an inventor. He has worked alongside distinguished colleagues such as Manfred Keller and Jurgen Jauernig, combining their collective knowledge to push the boundaries of pharmaceutical innovation.
Conclusion: Frank-Christophe Lintz stands out as a remarkable inventor dedicated to advancing treatment options for pulmonary bacterial infections. His innovative patents and collaborations reflect a relentless pursuit of knowledge and improvement in the pharmaceutical field, marking him as a significant contributor to healthcare solutions. His efforts continue to influence the future of medicine, ensuring better outcomes for patients suffering from bacterial infections.